Unverified50% confidenceOpinionExact time

Regulatory agencies (such as the FDA and NMPA) are increasingly inclined to require prospective evidence when approving clinical AI products.

1

Sources

50%

Confidence

Medium-term (~90 days)

Relevance

10/8/2026

First Seen

Valid until: 1/6/2027

Sources

Google's AMIE Clinical Study Published in The Lancet: First Real-Clinic Validation of AI-Powered Medical History Taking

Related Entities

FDAcompany NMPAcompany

Related Claims

UnverifiedIn the pharmaceutical industry, regulatory agencies such as the FDA require that drugs must pass independent Phase III clinical trials before they can be marketed, and the trial data must be publicly disclosed for peer review.69% similar

Cite This Claim

Stable URI

https://kongchang.com/claim/990061

API

curl https://kongchang.com/api/v1/knowledge/claims/990061

MCP

get_claim(id=990061)